Efficacy of once-daily, single-inhaler, fixed-dose combination of mometasone/indacaterol/glycopyrronium in patients with asthma with or without persistent airflow limitation: Post hoc analysis from the IRIDIUM study.

Respiratory medicine（2023）

引用 0|浏览24

暂无评分

摘要

Once-daily fixed-dose MF/IND/GLY was efficacious in asthma patients with and without persistent airflow limitation.

查看译文

关键词

Asthma,Efficacy,Exacerbations,Long-acting muscarinic antagonist,Lung function,Persistent airflow limitation

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要